{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:16:24Z","timestamp":1764731784526,"version":"3.46.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00718-w","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:14:42Z","timestamp":1764731682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel insight into CFTR gene\u2019s single nucleotide variants classification via in-silico analysis of a conserved site"],"prefix":"10.1007","volume":"40","author":[{"given":"Hassan","family":"Rafique","sequence":"first","affiliation":[]},{"given":"Anum","family":"Safdar","sequence":"additional","affiliation":[]},{"given":"Muhammad Usman","family":"Ghani","sequence":"additional","affiliation":[]},{"given":"Muhammad Umer","family":"Khan","sequence":"additional","affiliation":[]},{"given":"Zohair","family":"Mehdi","sequence":"additional","affiliation":[]},{"given":"Hajra","family":"Aqeel","sequence":"additional","affiliation":[]},{"given":"Iqra","family":"Arshad CH","sequence":"additional","affiliation":[]},{"given":"Hafiz Muzzammel","family":"Rehman","sequence":"additional","affiliation":[]},{"given":"Faheem","family":"Kanwal","sequence":"additional","affiliation":[]},{"given":"Qurban","family":"Ali","sequence":"additional","affiliation":[]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[]},{"given":"Ajaz","family":"Ahmad","sequence":"additional","affiliation":[]},{"given":"Adnan","family":"Iqbal","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"718_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/0471142905.hg0720s76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. https:\/\/doi.org\/10.1002\/0471142905.hg0720s76","journal-title":"Curr Protoc Hum Genet"},{"issue":"4","key":"718_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248\u2013249. https:\/\/doi.org\/10.1038\/nmeth0410-248","journal-title":"Nat Methods"},{"issue":"1","key":"718_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s40792-019-0701-y","volume":"5","author":"Z Alattar","year":"2019","unstructured":"Alattar Z, Thornley C, Behbahaninia M, Sisley A (2019) Proximal small bowel obstruction in a patient with cystic fibrosis: a case report. Surg Case Rep 5(1):143. https:\/\/doi.org\/10.1186\/s40792-019-0701-y","journal-title":"Surg Case Rep"},{"issue":"4","key":"718_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5144\/0256-4947.2020.321","volume":"40","author":"T AlMaghamsi","year":"2020","unstructured":"AlMaghamsi T, Iqbal N, Al-Esaei NA, Mohammed M, Eddin KZ, Ghurab F, Moghrabi N, Heaphy E, Junaid I (2020) Cystic fibrosis gene mutations and polymorphisms in Saudi men with infertility. Ann Saudi Med 40(4):321\u2013329. https:\/\/doi.org\/10.5144\/0256-4947.2020.321","journal-title":"Ann Saudi Med"},{"issue":"1","key":"718_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.54112\/bbasr.v2023i1.48","volume":"2023","author":"F Amin","year":"2023","unstructured":"Amin F, Hassan N, Bashir K, Khan A, Bibi H, Irshad M, Khan S, Nawaz K, Ullah Z (2023) Antimicrobial susceptibility profile of various bacteria isolated from respiratory tract infection. Bull Biol Allied Sci Res 2023(1):48\u201348","journal-title":"Bull Biol Allied Sci Res"},{"issue":"1","key":"718_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.54112\/bbasr.v2018i1.13","volume":"2018","author":"N Amjad","year":"2018","unstructured":"Amjad N, Rehman M, Khalid M, Amjad I (2018) Construction of the infectious molecule of beta satellite associated with ageratum yellow vein disease of Ageratum conyzoides. Bull Biol Allied Sci Res 2018(1):13\u201313","journal-title":"Bull Biol Allied Sci Res"},{"issue":"1","key":"718_CR7","doi-asserted-by":"publisher","DOI":"10.54112\/bbasr.v2024i1.60","volume":"2024","author":"SJ Awan","year":"2024","unstructured":"Awan SJ, Fatima Z, Kamran S, Khan AS, Fatima T, Imran S, Shabbir M, Nadeem SI (2024) Guar gum in therapeutics: a succinct exploration. Bullet Biol Allied Sci Res 2024(1):60. https:\/\/doi.org\/10.54112\/bbasr.v2024i1.60","journal-title":"Bullet Biol Allied Sci Res"},{"issue":"2","key":"718_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jcf.2018.07.001","volume":"18","author":"NT Awatade","year":"2019","unstructured":"Awatade NT, Ramalho S, Silva IAL, Fel\u00edcio V, Botelho HM, de Poel E, Vonk A, Beekman JM, Farinha CM, Amaral MD (2019) R560S: a class II CFTR mutation that is not rescued by current modulators. J Cyst Fibros 18(2):182\u2013189. https:\/\/doi.org\/10.1016\/j.jcf.2018.07.001","journal-title":"J Cyst Fibros"},{"key":"718_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175396","volume":"938","author":"M Bacalhau","year":"2023","unstructured":"Bacalhau M, Ferreira FC, Kmit A, Souza FR, da Silva VD, Pimentel AS, Amaral MD, Buarque CD, Lopes-Pacheco M (2023) Identification of novel F508del-CFTR traffic correctors among triazole derivatives. Eur J Pharmacol 938:175396. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175396","journal-title":"Eur J Pharmacol"},{"key":"718_CR10","doi-asserted-by":"publisher","first-page":"eS8","DOI":"10.1016\/S0929-693X(20)30044-0","volume":"27","author":"C Bareil","year":"2020","unstructured":"Bareil C, Bergougnoux A (2020) CFTR gene variants, epidemiology and molecular pathology. Arch Pediatr 27:eS8\u2013eS12. https:\/\/doi.org\/10.1016\/S0929-693X(20)30044-0","journal-title":"Arch Pediatr"},{"issue":"3","key":"718_CR11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.21037\/tau.2020.04.05","volume":"10","author":"JM Bieniek","year":"2021","unstructured":"Bieniek JM, Lapin CD, Jarvi KA (2021) Genetics of CFTR and male infertility. Transl Androl Urol 10(3):1391\u20131400. https:\/\/doi.org\/10.21037\/tau.2020.04.05","journal-title":"Transl Androl Urol"},{"key":"718_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-s3-s2","author":"E Capriotti","year":"2013","unstructured":"Capriotti E, Altman RB, Bromberg Y (2013) Collective judgment predicts disease-associated single nucleotide variants. BMC Genomics. https:\/\/doi.org\/10.1186\/1471-2164-14-s3-s2","journal-title":"BMC Genomics"},{"key":"718_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012619.pub3","author":"W Carroll","year":"2021","unstructured":"Carroll W, Green J, Gilchrist FJ (2021) Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD012619.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"718_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng J, Novati G, Pan J, Bycroft C, \u017demgulyt\u0117 A, Applebaum T, Pritzel A, Wong LH, Zielinski M, Sargeant T, Schneider RG, Senior AW, Jumper J, Hassabis D, Kohli P, Avsec \u017d (2023) Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381:eadg7492. https:\/\/doi.org\/10.1126\/science.adg7492","journal-title":"Science"},{"issue":"19","key":"718_CR15","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2174\/13816128113199990318","volume":"19","author":"M D Amaral","year":"2013","unstructured":"D Amaral M, M Farinha C (2013) Rescuing mutant CFTR: a multi-task approach to a better outcome in treating cystic fibrosis. Curr Pharm Des 19(19):3497\u20133508","journal-title":"Curr Pharm Des"},{"issue":"4","key":"718_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jcf.2013.12.003","volume":"13","author":"K De Boeck","year":"2014","unstructured":"De Boeck K, Zolin A, Cuppens H, Olesen HV, Viviani L (2014) The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. J Cyst Fibros 13(4):403\u2013409. https:\/\/doi.org\/10.1016\/j.jcf.2013.12.003","journal-title":"J Cyst Fibros"},{"issue":"3","key":"718_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s10038-020-00859-w","volume":"66","author":"MB Duz","year":"2021","unstructured":"Duz MB, Ozyavuz Cubuk P (2021) Analysis of rearrangements of the CFTR gene in patients from Turkey with CFTR-related disorders: frequent exon 2 deletion. J Hum Genet 66(3):315\u2013320. https:\/\/doi.org\/10.1038\/s10038-020-00859-w","journal-title":"J Hum Genet"},{"key":"718_CR18","doi-asserted-by":"publisher","first-page":"eS4","DOI":"10.1016\/S0929-693X(20)30043-9","volume":"27","author":"C F\u00e9rec","year":"2020","unstructured":"F\u00e9rec C, Scotet V (2020) Genetics of cystic fibrosis: basics. Arch Pediatr 27:eS4\u2013eS7. https:\/\/doi.org\/10.1016\/S0929-693X(20)30043-9","journal-title":"Arch Pediatr"},{"issue":"06","key":"718_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1055\/s-0039-1697591","volume":"40","author":"ME Gabel","year":"2019","unstructured":"Gabel ME, Galante GJ, Freedman SD (2019) Gastrointestinal and hepatobiliary disease in cystic fibrosis. Semin Respir Crit Care Med 40(06):825\u2013841. https:\/\/doi.org\/10.1055\/s-0039-1697591","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"718_CR20","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.3928\/19382359-20190327-01","volume":"48","author":"D Goetz","year":"2019","unstructured":"Goetz D, Ren CL (2019) Review of cystic fibrosis. Pediatr Ann 48(4):e154\u2013e161. https:\/\/doi.org\/10.3928\/19382359-20190327-01","journal-title":"Pediatr Ann"},{"key":"718_CR21","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","volume":"18","author":"A Granados","year":"2019","unstructured":"Granados A, Chan CL, Ode KL, Moheet A, Moran A, Holl R (2019) Cystic fibrosis related diabetes: pathophysiology, screening and diagnosis. J Cyst Fibros 18:S3\u2013S9. https:\/\/doi.org\/10.1016\/j.jcf.2019.08.016","journal-title":"J Cyst Fibros"},{"issue":"21","key":"718_CR22","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMe1712335","volume":"377","author":"H Grasemann","year":"2017","unstructured":"Grasemann H (2017) CFTR modulator therapy for cystic fibrosis. N Engl J Med 377(21):2085\u20132088","journal-title":"N Engl J Med"},{"issue":"2","key":"718_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tips.2012.11.006","volume":"34","author":"JW Hanrahan","year":"2013","unstructured":"Hanrahan JW, Sampson HM, Thomas DY (2013) Novel pharmacological strategies to treat cystic fibrosis. Trends Pharmacol Sci 34(2):119\u2013125. https:\/\/doi.org\/10.1016\/j.tips.2012.11.006","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"718_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.54112\/bbasr.v2023i1.49","volume":"2023","author":"N Hassan","year":"2023","unstructured":"Hassan N, Amin F, Bashir K, Irshad M, Jamil S, Munawar N, Haqqani H, Shabir H, Khan M (2023) Antiviral response of drugs used against hbv patients of Khyber Pakhtunkhwa, Pakistan. Bull Biol Allied Sci Res 2023(1):49\u201349","journal-title":"Bull Biol Allied Sci Res"},{"issue":"11","key":"718_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015458","volume":"5","author":"H Hoelen","year":"2010","unstructured":"Hoelen H, Kleizen B, Schmidt A, Richardson J, Charitou P, Thomas PJ, Braakman I (2010) The primary folding defect and rescue of \u0394F508 CFTR emerge during translation of the mutant domain. PLoS ONE 5(11):e15458. https:\/\/doi.org\/10.1371\/journal.pone.0015458","journal-title":"PLoS ONE"},{"issue":"10","key":"718_CR26","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1113\/jphysiol.2009.171595","volume":"587","author":"TC Hwang","year":"2009","unstructured":"Hwang TC, Sheppard DN (2009) Gating of the CFTR Cl- channel by ATP-driven nucleotide-binding domain dimerisation. J Physiol 587(10):2151\u20132161. https:\/\/doi.org\/10.1113\/jphysiol.2009.171595","journal-title":"J Physiol"},{"key":"718_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/2023.02.04.527134","author":"M Kim","year":"2023","unstructured":"Kim M, McDonald EF, Sabusap CMP, Timalsina B, Joshi D, Hong JS, Rab A, Sorscher EJ, Plate L (2023) Elexacaftor\/VX-445-mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics. bioRxiv. https:\/\/doi.org\/10.1101\/2023.02.04.527134","journal-title":"bioRxiv"},{"key":"718_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210358","author":"K Kleinfelder","year":"2023","unstructured":"Kleinfelder K, Villella VR, Hristodor AM, Laudanna C, Castaldo G, Amato F, Melotti P, Sorio C (2023) Theratyping of the rare CFTR genotype A559T in rectal organoids and nasal cells reveals a relevant response to elexacaftor (VX-445) and tezacaftor (VX-661) combination. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241210358","journal-title":"Int J Mol Sci"},{"key":"718_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12890-015-0120-1","volume":"15","author":"N Lenherr","year":"2015","unstructured":"Lenherr N, Lur\u00e0 M, Trachsel D, Latzin P, Hammer J (2015) Ivacaftor in a young boy with the rare gating mutation S549R\u2013use of lung clearance index to track progress: a case report. BMC Pulm Med 15:123. https:\/\/doi.org\/10.1186\/s12890-015-0120-1","journal-title":"BMC Pulm Med"},{"issue":"2","key":"718_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/sj.emboj.7600040","volume":"23","author":"HA Lewis","year":"2004","unstructured":"Lewis HA, Buchanan SG, Burley SK, Conners K, Dickey M, Dorwart M, Fowler R, Gao X, Guggino WB, Hendrickson WA (2004) Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J 23(2):282\u2013293","journal-title":"EMBO J"},{"issue":"1","key":"718_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2017.02.024","volume":"169","author":"F Liu","year":"2017","unstructured":"Liu F, Zhang Z, Csan\u00e1dy L, Gadsby DC, Chen J (2017) Molecular structure of the human CFTR ion channel. Cell 169(1):85-95.e88. https:\/\/doi.org\/10.1016\/j.cell.2017.02.024","journal-title":"Cell"},{"issue":"1","key":"718_CR32","doi-asserted-by":"publisher","DOI":"10.54112\/bbasr.v2024i1.85","volume":"2024","author":"A Malik","year":"2024","unstructured":"Malik A, Islam J, Zaib G, Ashraf MH, Zahid A, Rashid AR (2024) Role of oxidative stress and immune response alterations in asthmatic pregnant females. Bull Biol Allied Sci Res 2024(1):85. https:\/\/doi.org\/10.54112\/bbasr.v2024i1.85","journal-title":"Bull Biol Allied Sci Res"},{"issue":"1","key":"718_CR33","doi-asserted-by":"publisher","DOI":"10.54112\/bbasr.v2024i1.87","volume":"2024","author":"A Malik","year":"2024","unstructured":"Malik A, Islam J, Zaib G, Ashraf MH, Zahid A, Rashid AR, Zia T, Ali Q (2024) Smog crisis in Lahore: evaluating air quality trends and public health implications. Bull Biol Allied Sci Res 2024(1):87. https:\/\/doi.org\/10.54112\/bbasr.v2024i1.87","journal-title":"Bull Biol Allied Sci Res"},{"issue":"1","key":"718_CR34","doi-asserted-by":"publisher","DOI":"10.54112\/bbasr.v2024i1.86","volume":"2024","author":"A Malik","year":"2024","unstructured":"Malik A, Islam J, Zaib G, Saadia H, Zahid A (2024) Correlation of oxidative stress markers in multiple biofluids of end-stage renal disease patients. Bull Biol Allied Sci Res 2024(1):86. https:\/\/doi.org\/10.54112\/bbasr.v2024i1.86","journal-title":"Bull Biol Allied Sci Res"},{"key":"718_CR35","doi-asserted-by":"crossref","unstructured":"Mall MA, Hartl D (2014) CFTR: cystic fibrosis and beyond. In: Eur Respiratory Soc.","DOI":"10.1183\/09031936.00228013"},{"issue":"8","key":"718_CR36","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/S2213-2600(16)30188-6","volume":"4","author":"FAL Marson","year":"2016","unstructured":"Marson FAL, Bertuzzo CS, Ribeiro JD (2016) Classification of CFTR mutation classes. Lancet Respir Med 4(8):e37\u2013e38","journal-title":"Lancet Respir Med"},{"issue":"2","key":"718_CR37","first-page":"59","volume":"2","author":"M Mergiotti","year":"2022","unstructured":"Mergiotti M, Murabito A, Prono G, Ghigo A (2022) CFTR modulator therapy for rare CFTR mutants. J Respir 2(2):59\u201376","journal-title":"J Respir"},{"key":"718_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2021.100286","volume":"27","author":"L Merjaneh","year":"2022","unstructured":"Merjaneh L, Hasan S, Kasim N, Ode KL (2022) The role of modulators in cystic fibrosis related diabetes. J Clin Transl Endocrinol 27:100286. https:\/\/doi.org\/10.1016\/j.jcte.2021.100286","journal-title":"J Clin Transl Endocrinol"},{"key":"718_CR39","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.amsu.2020.11.063","volume":"60","author":"CAM Morales","year":"2020","unstructured":"Morales CAM, Gonzalez-Urquijo M, Flores LFM, Quevedo-Fernandez E, Huerta EAG, Hern\u00e1ndez-Torre MMV (2020) Proximal intestinal obstruction syndrome (PIOS) in a patient with cystic fibrosis: a case report. Ann Med Surg 60:669\u2013672. https:\/\/doi.org\/10.1016\/j.amsu.2020.11.063","journal-title":"Ann Med Surg"},{"issue":"1","key":"718_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00018-016-2390-z","volume":"74","author":"O Moran","year":"2017","unstructured":"Moran O (2017) The gating of the CFTR channel. Cell Mol Life Sci 74(1):85\u201392. https:\/\/doi.org\/10.1007\/s00018-016-2390-z","journal-title":"Cell Mol Life Sci"},{"issue":"33-34","key":"718_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3238\/arztebl.2017.0564","volume":"114","author":"S Naehrig","year":"2017","unstructured":"Naehrig S, Chao CM, Naehrlich L (2017) Cystic fibrosis. Dtsch Arztebl Int 114(33\u201334):564\u2013574. https:\/\/doi.org\/10.3238\/arztebl.2017.0564","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"718_CR42","doi-asserted-by":"publisher","DOI":"10.54112\/bbasr.v2024i1.68","volume":"2024","author":"K Nawaz","year":"2024","unstructured":"Nawaz K, Khan S, Bibi A (2024) Insights into scabies prevalence and risk factors. Bullet Biol Allied Sci Res 2024(1):68. https:\/\/doi.org\/10.54112\/bbasr.v2024i1.68","journal-title":"Bullet Biol Allied Sci Res"},{"issue":"D1","key":"718_CR43","doi-asserted-by":"publisher","first-page":"D418","DOI":"10.1093\/nar\/gkac993","volume":"51","author":"T Paysan-Lafosse","year":"2022","unstructured":"Paysan-Lafosse T, Blum M, Chuguransky S, Grego T, Pinto BL, Salazar GA, Bileschi ML, Bork P, Bridge A, Colwell L, Gough J, Haft DH, Letuni\u0107 I, Marchler-Bauer A, Mi H, Natale DA, Orengo CA, Pandurangan AP, Rivoire C, Bateman A (2022) InterPro in 2022. Nucleic Acids Res 51(D1):D418\u2013D427. https:\/\/doi.org\/10.1093\/nar\/gkac993","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"718_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19669-x","volume":"11","author":"V Pejaver","year":"2020","unstructured":"Pejaver V, Urresti J, Lugo-Martinez J, Pagel KA, Lin GN, Nam H-J, Mort M, Cooper DN, Sebat J, Iakoucheva LM, Mooney SD, Radivojac P (2020) Inferring the molecular and phenotypic impact of amino acid variants with MutPred2. Nat Commun 11(1):5918. https:\/\/doi.org\/10.1038\/s41467-020-19669-x","journal-title":"Nat Commun"},{"issue":"5","key":"718_CR45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u20134023. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"718_CR46","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009761","author":"SM Rowe","year":"2013","unstructured":"Rowe SM, Verkman AS (2013) Cystic fibrosis transmembrane regulator correctors and potentiators. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a009761","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"47","key":"718_CR47","doi-asserted-by":"publisher","first-page":"17891","DOI":"10.1073\/pnas.0608312103","volume":"103","author":"M Roxo-Rosa","year":"2006","unstructured":"Roxo-Rosa M, Xu Z, Schmidt A, Neto M, Cai Z, Soares CM, Sheppard DN, Amaral MD (2006) Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms. Proc Natl Acad Sci U S A 103(47):17891\u201317896. https:\/\/doi.org\/10.1073\/pnas.0608312103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"718_CR48","volume":"7","author":"C Safi","year":"2019","unstructured":"Safi C, Zheng Z, Dimango E, Keating C, Gudis DA (2019) Chronic rhinosinusitis in cystic fibrosis: diagnosis and medical management. Med Sci 7(2):32","journal-title":"Med Sci"},{"issue":"1","key":"718_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jcf.2014.06.008","volume":"14","author":"H Sharma","year":"2015","unstructured":"Sharma H, Jollivet Souchet M, Callebaut I, Prasad R, Becq F (2015) Function, pharmacological correction and maturation of new Indian CFTR gene mutations. J Cyst Fibros 14(1):34\u201341. https:\/\/doi.org\/10.1016\/j.jcf.2014.06.008","journal-title":"J Cyst Fibros"},{"key":"718_CR50","doi-asserted-by":"publisher","unstructured":"Sheema, Bashir K, Fiaz S, Khan AW, Haqqani S, Bibi A, Nawaz K, Khan MA, Ullah A (2024). Molecular identification of HCV genotypes among injecting drug users having HCV and HIV co-infection. Bullet Biol Allied Sci Res, 2024(1), 71. https:\/\/doi.org\/10.54112\/bbasr.v2024i1.71","DOI":"10.54112\/bbasr.v2024i1.71"},{"issue":"1","key":"718_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1479-7364-8-11","volume":"8","author":"HA Shihab","year":"2014","unstructured":"Shihab HA, Gough J, Mort M, Cooper DN, Day IN, Gaunt TR (2014) Ranking non-synonymous single nucleotide polymorphisms based on disease concepts. Hum Genomics 8(1):11. https:\/\/doi.org\/10.1186\/1479-7364-8-11","journal-title":"Hum Genomics"},{"issue":"1","key":"718_CR52","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1038\/s41467-020-18101-8","volume":"11","author":"H Shishido","year":"2020","unstructured":"Shishido H, Yoon JS, Yang Z, Skach WR (2020) CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates. Nat Commun 11(1):4258. https:\/\/doi.org\/10.1038\/s41467-020-18101-8","journal-title":"Nat Commun"},{"key":"718_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010966.pub2","author":"KW Southern","year":"2018","unstructured":"Southern KW, Patel S, Sinha IP, Nevitt SJ (2018) Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010966.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"718_CR54","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","volume":"377","author":"JL Taylor-Cousar","year":"2017","unstructured":"Taylor-Cousar JL, Munck A, McKone EF, van der Ent CK, Moeller A, Simard C, Wang LT, Ingenito EP, McKee C, Lu Y, Lekstrom-Himes J, Elborn JS (2017) Tezacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del. N Engl J Med 377(21):2013\u20132023. https:\/\/doi.org\/10.1056\/NEJMoa1709846","journal-title":"N Engl J Med"},{"issue":"5","key":"718_CR55","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1085\/jgp.201010399","volume":"135","author":"MF Tsai","year":"2010","unstructured":"Tsai MF, Li M, Hwang TC (2010) Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel. J Gen Physiol 135(5):399\u2013414. https:\/\/doi.org\/10.1085\/jgp.201010399","journal-title":"J Gen Physiol"},{"issue":"1","key":"718_CR56","doi-asserted-by":"publisher","DOI":"10.54112\/bbasr.v2024i1.64","volume":"2024","author":"A Ullah","year":"2024","unstructured":"Ullah A, Bibi A, Ullah I, Kayani REZ, Asim M, Munawar N, Amjad M, Siraj M, Gohar M, Khan MA (2024) An overview of hepatitis c virus and liver cirrhosis in Pakistan. Bullet Biol Allied Sci Res 2024(1):64. https:\/\/doi.org\/10.54112\/bbasr.v2024i1.64","journal-title":"Bullet Biol Allied Sci Res"},{"issue":"1","key":"718_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.54112\/bbasr.v2023i1.42","volume":"2023","author":"I Ullah","year":"2023","unstructured":"Ullah I, Ullah A, Rehman S, Ullah S, Ullah H, Haqqni S, Amir M, Gul F, Bashir K (2023) Prevalence and risk factors of helicobacter pylori infection among individuals with tobacco consumption habits in district Peshawar: a cross-sectional study. Bull Biol Allied Sci Res 2023(1):42\u201342","journal-title":"Bull Biol Allied Sci Res"},{"issue":"1","key":"718_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nprot.2015.123","volume":"11","author":"R Vaser","year":"2016","unstructured":"Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC (2016) SIFT missense predictions for genomes. Nat Protoc 11(1):1\u20139. https:\/\/doi.org\/10.1038\/nprot.2015.123","journal-title":"Nat Protoc"},{"issue":"5","key":"718_CR59","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jcf.2021.03.011","volume":"20","author":"G Veit","year":"2021","unstructured":"Veit G, Vaccarin C, Lukacs GL (2021) Elexacaftor co-potentiates the activity of F508del and gating mutants of CFTR. J Cyst Fibros 20(5):895\u2013898. https:\/\/doi.org\/10.1016\/j.jcf.2021.03.011","journal-title":"J Cyst Fibros"},{"issue":"1","key":"718_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-548","volume":"11","author":"H Venselaar","year":"2010","unstructured":"Venselaar H, te Beek TAH, Kuipers RKP, Hekkelman ML, Vriend G (2010) Protein structure analysis of mutations causing inheritable diseases. An e-science approach with life scientist friendly interfaces. BMC Bioinformatics 11(1):548. https:\/\/doi.org\/10.1186\/1471-2105-11-548","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"718_CR61","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","volume":"73","author":"MJ Welsh","year":"1993","unstructured":"Welsh MJ, Smith AE (1993) Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73(7):1251\u20131254","journal-title":"Cell"},{"issue":"3","key":"718_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4582","volume":"32","author":"B Yariv","year":"2023","unstructured":"Yariv B, Yariv E, Kessel A, Masrati G, Chorin AB, Martz E, Mayrose I, Pupko T, Ben-Tal N (2023) Using evolutionary data to make sense of macromolecules with a \u201cface-lifted\u201d consurf. Protein Sci 32(3):e4582. https:\/\/doi.org\/10.1002\/pro.4582","journal-title":"Protein Sci"},{"issue":"7","key":"718_CR63","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16144","volume":"13","author":"A Zaher","year":"2021","unstructured":"Zaher A, ElSaygh J, Elsori D, ElSaygh H, Sanni A (2021) A review of Trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy. Cureus 13(7):e16144. https:\/\/doi.org\/10.7759\/cureus.16144","journal-title":"Cureus"},{"issue":"4","key":"718_CR64","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1085\/jgp.200609622","volume":"128","author":"Z Zhou","year":"2006","unstructured":"Zhou Z, Wang X, Liu HY, Zou X, Li M, Hwang TC (2006) The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics. J Gen Physiol 128(4):413\u2013422. https:\/\/doi.org\/10.1085\/jgp.200609622","journal-title":"J Gen Physiol"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00718-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00718-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00718-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:14:44Z","timestamp":1764731684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00718-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00718-w","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No ethical approval was required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"12"}}